Recommended
More Related Content
Viewers also liked
Recently uploaded
Recently uploaded (20)
Gouty arthritis (gout) pipeline review, h2 2015
- 1. Gouty Arthritis (Gout) - Pipeline Review, H2 2015 TELEPHONE: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
- 2. Report Overview Scope The report provides a snapshot of the global therapeutic landscape of Gouty Arthritis (Gout) The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Gouty Arthritis (Gout) and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects A review of the Gouty Arthritis (Gout) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Gouty Arthritis (Gout) pipeline on the basis of target, MoA, route of administration and molecule type Read More At: http://www.researchbeam.com/gouty-arthritis-gout-pipeline-review-h2-2015-market
- 3. Table of Content List of Figures Number of Products under Development for Gouty Arthritis (Gout), H2 2015 11 Number of Products under Development for Gouty Arthritis (Gout) - Comparative Analysis, H2 2015 12 Number of Products under Development by Companies, H2 2015 13 Comparative Analysis by Late Stage Development, H2 2015 16 Comparative Analysis by Clinical Stage Development, H2 2015 17 Comparative Analysis by Early Stage Products, H2 2015 18 Assessment by Monotherapy Products, H2 2015 42 Number of Products by Top 10 Targets, H2 2015 43 Number of Products by Stage and Top 10 Targets, H2 2015 43 Number of Products by Top 10 Mechanism of Actions, H2 2015 45 Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 45 Number of Products by Routes of Administration, H2 2015 47 Number of Products by Stage and Routes of Administration, H2 2015 47 Number of Products by Molecule Types, H2 2015 49 Number of Products by Stage and Molecule Types, H2 2015 49
- 4. Report Overview Reasons to buy Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Develop strategic initiatives by understanding the focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Gouty Arthritis (Gout) Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Gouty Arthritis (Gout) pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Enquire At : http://www.researchbeam.com/gouty-arthritis-gout-pipeline-review-h2-2015- market/enquire-about-report
- 5. FOR MORE DETAILS Visit us at : Stay With Us: http://www.researchbeam.com/gouty-arthritis-gout-pipeline-review-h2-2015-market 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States TELEPHONE: +1 (800) 910-6452 DIRECT: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com